Comparison of hospital treatment strategy or of treatment actually received in COVID-19?: Commenting on: Lammers AJJ, Brohet RM, Theunissen REP, Koster C, Rood R, Verhagen DWM, et al. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients. Int J Infect Dis. 2020 September.

Sikkens, Jonne J; Collard, Didier; Peters, Edgar J G

Sikkens, Jonne J; Collard, Didier; Peters, Edgar J G.

Afiliación

Sikkens JJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands. Electronic address: j.sikkens@amsterdamumc.nl.
Collard D; Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Meibergdreef 9, Amsterdam, The Netherlands.
Peters EJG; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands.

Int J Infect Dis ; 103: 516, 2021 02.

Article en En | MEDLINE | ID: mdl-33310025

Asunto(s)

Tratamiento Farmacológico de COVID-19; Hidroxicloroquina; Cloroquina/uso terapéutico; Hospitales; Humanos; Hidroxicloroquina/uso terapéutico; Unidades de Cuidados Intensivos; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Hidroxicloroquina Límite: Humans Idioma: En Revista: Int J Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2021 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google